Britain Grants Emergency Approval of New COVID-19 Vaccine Developed by U.S.-Based Pfizer and Germany’s BioNTech
'Historic moment' makes Britain first Western nation preparing to begin mass inoculations against novel coronavirus
Full Article
Britain Grants Emergency Approval of New COVID-19 Vaccine Developed by U.S.-Based Pfizer and Germany’s BioNTech
VOA News
0 shares
1 views
You might like
Related news coverage
Cut off: Britain hit with travel bans over new virus strain
SeattlePI.com
LONDON (AP) — Trucks waiting to get out of Britain backed up for miles and people were stranded at airports Monday as countries..
Advertisement
More coverage
Experts propose vaccine priority list as German deaths rise
SeattlePI.com
BERLIN (AP) — An independent expert team on Thursday recommended that people over age 80, residents and staff in nursing homes,..
-
EXPLAINER: Why is the EU taking so long to OK vaccine?
SeattlePI.com
-
Germany demands EU agency approve vaccine before Christmas
SeattlePI.com
-
The Latest: Germany pushes for quick EU vaccine approval
SeattlePI.com
-
Germany's heath chief urges EU to approve vaccine faster
SeattlePI.com